Harry H Mansbach is Chief Medical Officer of 89bio, Inc.. Currently has a direct ownership of 247,039 shares of ETNB, which is worth approximately $1.98 Million. The most recent transaction as insider was on Feb 17, 2022, when has been sold 22,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 247K
62.48% 3M change
146.64% 12M change
Total Value Held $1.98 Million

Harry H Mansbach Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 17 2022
BUY
Grant, award, or other acquisition
-
22,500 Added 40.91%
32,500 Common Stock
Feb 05 2022
SELL
Payment of exercise price or tax liability
$7,128 $5.23 p/Share
1,363 Reduced 4.19%
31,137 Common Stock
Feb 05 2021
BUY
Grant, award, or other acquisition
-
10,000 Added 50.0%
10,000 Common Stock
HHM

Harry H Mansbach

Chief Medical Officer
San Francisco, CA

Track Institutional and Insider Activities on ETNB

Follow 89bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ETNB shares.

Notify only if

Insider Trading

Get notified when an 89bio, Inc. insider buys or sells ETNB shares.

Notify only if

News

Receive news related to 89bio, Inc.

Track Activities on ETNB